Loading...
Long-term disease control by trabectedin in a patient with dedifferentiated liposarcoma: A case report
RATIONALE: Trabectedin is an antitumor drug considered to be effective for liposarcoma, leiomyosarcoma, and translocation-related sarcoma. Concerning liposarcoma subtypes, evidence of the efficacy of trabectedin for dedifferentiated liposarcoma (DDLPS) is poor, whereas it is known to have high effic...
Saved in:
| Published in: | Medicine (Baltimore) |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Wolters Kluwer Health
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6959950/ https://ncbi.nlm.nih.gov/pubmed/31914068 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000018689 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|